EDF1
Endothelial differentiation-related factor 1
Also known as: CFAP280, EDF-1, EDF1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60869
- Gene
- EDF1
- Ensembl
- ENSG00000107223
- Chromosome
- 9
- Canonical length
- 148 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a protein that may regulate endothelial cell differentiation, lipid metabolism, and hormone-induced cardiomyocyte hypertrophy. The encoded protein has also been found to act as a transcriptional coactivator by interconnecting the general transcription factor TATA element-binding protein (TBP) and gene-specific activators. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
148 residues, UniProt reviewed canonical sequence.
>O60869|EDF1
1 MAESDWDTVT VLRKKGPTAA QAKSKQAILA AQRRGEDVET SKKWAAGQNK QHSITKNTAK
61 LDRETEELHH DRVTLEVGKV IQQGRQSKGL TQKDLATKIN EKPQVIADYE SGRAIPNNQV
121 LGKIERAIGL KLRGKDIGKP IEKGPRAKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EDF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 677 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 677 nTPM
- liver: 625 nTPM
- choroid plexus: 566 nTPM
- heart muscle: 481 nTPM
- skeletal muscle: 469 nTPM
- salivary gland: 468 nTPM
Single-cell type
- esophageal apical cells: 2,970 nCPM
- enterocytes: 2,429 nCPM
- esophageal suprabasal cells: 1,513 nCPM
- syncytiotrophoblasts: 1,388 nCPM
- colonocytes: 1,311 nCPM
- pancreatic acinar cells: 1,142 nCPM
Immune cell
- plasmacytoid DC: 623 nTPM
- total PBMC: 545 nTPM
- T-reg: 472 nTPM
- memory B-cell: 433 nTPM
- naive B-cell: 403 nTPM
- NK-cell: 398 nTPM
Brain region
- cerebral cortex: 220 nTPM
- hypothalamus: 206 nTPM
- medulla oblongata: 201 nTPM
- white matter: 195 nTPM
- midbrain: 195 nTPM
- pons: 195 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.78
- gnomAD missense Z
- 1.56
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endothelial cell differentiation
- positive regulation of DNA binding
- positive regulation of DNA-templated transcription
- regulation of DNA-templated transcription
- regulation of lipid metabolic process
Molecular functions
- calmodulin binding
- DNA binding
- RNA binding
- TFIID-class transcription factor complex binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cro/C1-type, helix-turn-helix domain
- Lambda repressor-like, DNA-binding domain superfamily
- Multiprotein bridging factor 1, N-terminal
- Helix-turn-helix
- Multiprotein bridging factor 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EDF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EDF1 as an antibody target. Whether an autoantibody or antibody against EDF1 could matter depends on whether native EDF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EDF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EDF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...